Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 8
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Remdesivir, on the road to DisCoVeRy.
Gyselinck I, Janssens W. Gyselinck I, et al. Lancet Infect Dis. 2022 Feb;22(2):153-155. doi: 10.1016/S1473-3099(21)00559-4. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534513 Free PMC article. No abstract available.
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.
Lorent N, Vande Weygaerde Y, Claeys E, Guler Caamano Fajardo I, De Vos N, De Wever W, Salhi B, Gyselinck I, Bosteels C, Lambrecht BN, Everaerts S, Verschraegen S, Schepers C, Demeyer H, Heyns A, Depuydt P, Oeyen S, Van Bleyenbergh P, Godinas L, Dupont L, Hermans G, Derom E, Gosselink R, Janssens W, Van Braeckel E. Lorent N, et al. Among authors: gyselinck i. ERJ Open Res. 2022 Apr 11;8(2):00004-2022. doi: 10.1183/23120541.00004-2022. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35415186 Free PMC article.
Distinct Airway Involvement in Subtypes of End-Stage Fibrotic Pulmonary Sarcoidosis.
Verleden SE, Vanstapel A, De Sadeleer L, Dubbeldam A, Goos T, Gyselinck I, Geudens V, Kaes J, Van Raemdonck DE, Ceulemans LJ, Yserbyt J, Vos R, Vanaudenaerde B, Weynand B, Verschakelen J, Wuyts WA. Verleden SE, et al. Among authors: gyselinck i. Chest. 2021 Aug;160(2):562-571. doi: 10.1016/j.chest.2021.01.003. Epub 2021 Jan 10. Chest. 2021. PMID: 33440183
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial.
Liesenborghs L, Spriet I, Jochmans D, Belmans A, Gyselinck I, Teuwen LA, Ter Horst S, Dreesen E, Geukens T, Engelen MM, Landeloos E, Geldhof V, Ceunen H, Debaveye B, Vandenberk B, Van der Linden L, Jacobs S, Langendries L, Boudewijns R, Do TND, Chiu W, Wang X, Zhang X, Weynand B, Vanassche T, Devos T, Meyfroidt G, Janssens W, Vos R, Vermeersch P, Wauters J, Verbeke G, De Munter P, Kaptein SJF, Rocha-Pereira J, Delang L, Van Wijngaerden E, Neyts J, Verhamme P. Liesenborghs L, et al. Among authors: gyselinck i. EBioMedicine. 2021 Apr;66:103288. doi: 10.1016/j.ebiom.2021.103288. Epub 2021 Mar 19. EBioMedicine. 2021. PMID: 33752127 Free PMC article. Clinical Trial.
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens".
Liesenborghs L, Spriet I, Jochmans D, Belmans A, Gyselinck I, Teuwen LA, Ter Horst S, Dreesen E, Geukens T, Engelen MM, Landeloos E, Geldhof V, Ceunen H, Debaveye B, Vandenberk B, Van der Linden L, Jacobs S, Langendries L, Boudewijns R, Dan Do TN, Chiu W, Wang X, Zhang X, Weynand B, Vanassche T, Devos T, Meyfroidt G, Janssens W, Vos R, Vermeersch P, Wauters J, Verbeke G, De Munter P, Kaptein SJF, Rocha-Pereira J, Delang L, Van Wijngaerden E, Neyts J, Verhamme P. Liesenborghs L, et al. Among authors: gyselinck i. EBioMedicine. 2021 Jul;69:103454. doi: 10.1016/j.ebiom.2021.103454. Epub 2021 Jun 26. EBioMedicine. 2021. PMID: 34186486 Free PMC article. No abstract available.
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus.
Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M. Ramakrishnan S, et al. Among authors: gyselinck i. Int J Chron Obstruct Pulmon Dis. 2021 Feb 16;16:321-332. doi: 10.2147/COPD.S287705. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33623379 Free PMC article.
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
Gyselinck I, Liesenborghs L, Landeloos E, Belmans A, Verbeke G, Verhamme P, Vos R, Janssens W; DAWn-Azithro consortium. Gyselinck I, et al. Trials. 2021 Mar 5;22(1):187. doi: 10.1186/s13063-021-05153-4. Trials. 2021. PMID: 33673831 Free PMC article. No abstract available.
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
Gyselinck I, Liesenborghs L, Landeloos E, Belmans A, Verbeke G, Verhamme P, Vos R, Janssens W; DAWn-Azithro consortium. Gyselinck I, et al. Trials. 2021 Feb 9;22(1):126. doi: 10.1186/s13063-021-05033-x. Trials. 2021. PMID: 33563325 Free PMC article.
15 results